#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

PL_starsi_muz_oko_kapky

Antiglaucoma Eye Drops with Preservatives – Higher Likelihood of Glaucoma Surgery?

18. 2. 2021 Source: Treatment of Glaucoma

A recently published French study sought to answer the question of whether there is a connection between the presence of preservatives in antiglaucoma eye drops and the probability of undergoing glaucoma surgery.

PL_CT_lekar_zprava

Quantitative CT as a New Tool for Evaluating COPD in Alpha-1 Antitrypsin Deficiency

For such a rare hereditary disorder as alpha-1 antitrypsin deficiency (AATD), we have so far used…
18. 2. 2021 Source: Deficiency of Alpha-1-Antitrypsin
léky_lékař

Intravenous Thrombolysis in Ischemic Stroke Patients on Dabigatran Treatment

What are the outcomes of performing intravenous thrombolysis in patients with acute ischemic stroke…
18. 2. 2021 Source: Anticoagulant Treatment
Lactobacillus reuteri

Lactobacillus reuteri − a natural probiotic with lifelong significance

Probiotics are often given to newborns within the first few days of life to alleviate infantile…
16. 2. 2021 Source: GI, colic and microbiome
PL_covid_zazivani_bricho_prujem_trakt_muz

State of the Intestinal Microbiome and COVID-19 Infection − Possible Correlations

Some patients infected with the SARS-CoV-2 virus exhibit gastrointestinal symptoms, including…
16. 2. 2021 Source: GI, colic and microbiome
Transfuze_krevni_banka

Safety Profile of Antiemetic Therapy in Patients Preparing for Hematopoietic Stem Cell Transplantation

An observational study conducted at a university clinic in Barcelona investigated the safety of the…
15. 2. 2021 Source: Antiemetic Therapy
Zvracení_nevolnot_žena_toaleta

Intravenous Fixed Combination NEPA in the Prevention of Chemotherapy-Induced Vomiting

Summary data from several studies were used by the authors of the following analysis to evaluate…
15. 2. 2021 Source: Antiemetic Therapy
Plíce_snímek_lékař_pacient

Brigatinib vs. Crizotinib in the Treatment of ALK-Positive NSCLC – Results of the Second Interim Analysis of the ALTA-1L Study

The anaplastic lymphoma kinase inhibitor brigatinib demonstrated superiority over crizotinib in the…
15. 2. 2021 Source: Non-Small Cell Lung Cancer
Plíce_snímek_tablet_lékaři

Good Efficacy of Brigatinib After Failure of 2nd Generation ALK Inhibitors

Brigatinib is commonly used in the treatment of ALK-positive non-small cell lung cancer (NSCLC) in…
15. 2. 2021 Source: Non-Small Cell Lung Cancer
prohlídka lékař pacient nemocnice medicína vyšetření pomoc ruce

Does olaparib improve overall survival in patients with recurrent ovarian cancer and BRCA mutation?

Olaparib, a poly(ADP-ribose) polymerase (PARP) enzyme inhibitor, in tablet form is indicated, among…
13. 2. 2021 Source: Ovarian and Breast Cancer
1 111 112 113 114 115 158
Filter by speciality
Remove filters

Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#